Health Canada is increasing transparency for the NHP industry by announcing that NHP GMP inspection results will be publicly available on the Drug and Health Product Inspection Database (DHPID) […]
The Compliance and Enforcement Division of the Consumer and Hazardous Products Safety Directorate (CHPSD) has published the Annual compliance verification report for 2024-2025. This annual report provides details on […]
The Cosmetic Notification Form (CNF) was recently updated on October 6, 2025, introducing several key changes to streamline the notification process and prepare for upcoming regulatory requirements. In Section […]
The TGA is currently investigating concerns raised by recent CHOICE testing regarding the SPF claims of several sunscreens on the Australian market. This investigation was triggered after products, including […]
On 14 September 2025, the Scientific Committee on Consumer Safety (SCCS) was mandated to review the safety of titanium dioxide, both nano and non-nano in cosmetic products. This review of the […]
ECHA recently ruled on Terpinyl Acetate Multiconstituent (EC 904-693-9), prohibiting a proposed OECD 443 animal test and instead mandating that the Lead Registrant (LR) self-classify the substance as CMR […]
On September 4, 2025, the Office of Information and Regulatory Affairs (OIRA) released the Spring 2025 Unified Agenda of Regulatory and Deregulatory Actions, outlining federal agencies’ intended regulatory activities over […]
Canada’s Chemicals Management Plan (CMP) program is sharing the following Risk Assessment Publication Plan to inform stakeholders of upcoming publications. The targeted publication dates are subject to change. The program […]
Health Canada has updated the 2022 version of the Guidance on management of drug submissions and applications. The changes to the guidance take effect immediately and will ensure that information […]
Health Canada is seeking feedback on proposed revisions to the Questions and Answers: Plain Language Labelling for Prescription Drugs Guidance Document. Revisions to the current guidance document have been […]
